Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPAS-AS Trial: Shexiang Tongxin Dropping Pills in Aortic Stenosis
ChiCTR2500111790Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in aortic stenosis (AS) comparing Shexiang Tongxin Dropping Pills + Standard treatment with Placebo + Standard treatment (2 arms). Primary endpoint: Left Ventricular Mass Index at 6 months. Started Nov 2025; status: recruiting.
02
Drugs
Shexiang Tongxin Dropping Pills
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on ChiCTR2500111790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111790.